Shareholders' equity · 2011–2025
Karyopharm Therapeutics shareholders' equity
−$293M−$107M · FY2025
Karyopharm Therapeutics (KPTI) reported −$293M in shareholders' equity for fiscal 2025, −$107M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$293M | −$107M | Open → |
| FY20242024-12-31 | −$186M | −$49.8M | Open → |
| FY20232023-12-31 | −$136M | −$120M | Open → |
| FY20222022-12-31 | −$16.7M | +$63.0M | Open → |
| FY20212021-12-31 | −$79.7M | −$130M | Open → |
| FY20202020-12-31 | $50.5M | +1.6% | Open → |
| FY20192019-12-31 | $49.8M | −72.8% | Open → |
| FY20182018-12-31 | $183M | +41.5% | Open → |
| FY20172017-12-31 | $129M | −20.2% | Open → |
| FY20162016-12-31 | $162M | −18.2% | Open → |
| FY20152015-12-31 | $198M | −4.1% | Open → |
| FY20142014-12-31 | $207M | +33.5% | Open → |
| FY20132013-12-31 | $155M | +$183M | Open → |
| FY20122012-12-31 | −$27.9M | −$15.2M | Open → |
| FY20112011-12-31 | −$12.7M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Karyopharm Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/karyopharm-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Karyopharm Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/karyopharm-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-karyopharm-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Karyopharm Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/karyopharm-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-347906 · August 13, 2026
{{cite web |title=Karyopharm Therapeutics shareholders' equity — 10-Q (0001193125-26-347906) |url=https://www.sec.gov/Archives/edgar/data/1503802/000119312526347906/kpti-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.